Sanofi (SNY)
NASDAQ: SNY · Real-Time Price · USD
47.32
+1.98 (4.38%)
Nov 4, 2026, 1:15 PM EST - Market open
Sanofi Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 113,351 | 118,181 | 121,098 | 124,405 | 120,407 | 126,457 | |
Market Cap Growth | -11.29% | -2.41% | -2.66% | 3.32% | -4.78% | 4.55% |
Enterprise Value | 129,292 | 133,584 | 138,970 | 139,164 | 136,107 | 140,166 |
Last Close Price | 45.33 | 46.60 | 44.96 | 44.99 | 42.67 | 42.96 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 24.33 | 12.88 | 21.04 | 20.84 | 13.46 | 17.87 |
PS Ratio | 1.88 | 2.15 | 2.64 | 2.74 | 2.80 | 2.84 |
PB Ratio | 1.31 | 1.40 | 1.50 | 1.51 | 1.50 | 1.61 |
P/TBV Ratio | 18.20 | 8.02 | 5.89 | 17.71 | 11.89 | 16.00 |
P/FCF Ratio | 9.68 | 11.20 | 15.92 | 13.03 | 12.52 | 12.30 |
P/OCF Ratio | 8.07 | 9.36 | 12.88 | 10.97 | 10.70 | 10.57 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.15 | 2.44 | 3.03 | 3.06 | 3.16 | 3.15 |
EV/EBITDA Ratio | 7.58 | 9.00 | 11.51 | 11.37 | 9.73 | 10.95 |
EV/EBIT Ratio | 9.92 | 11.79 | 15.14 | 15.50 | 12.27 | 14.39 |
EV/FCF Ratio | 11.10 | 12.66 | 18.27 | 14.57 | 14.16 | 13.63 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.27 | 0.28 | 0.23 | 0.25 | 0.28 | 0.33 |
Debt / EBITDA Ratio | 1.35 | 1.58 | 1.50 | 1.62 | 1.58 | 1.94 |
Debt / FCF Ratio | 1.99 | 2.27 | 2.44 | 2.13 | 2.36 | 2.48 |
Net Debt / Equity Ratio | 0.19 | 0.18 | 0.13 | 0.13 | 0.11 | 0.18 |
Net Debt / EBITDA Ratio | 0.96 | 1.01 | 0.89 | 0.87 | 0.64 | 1.09 |
Net Debt / FCF Ratio | 1.39 | 1.42 | 1.41 | 1.11 | 0.93 | 1.36 |
Asset Turnover | 0.39 | 0.36 | 0.34 | 0.33 | 0.33 | 0.33 |
Inventory Turnover | 0.54 | 1.32 | 1.38 | 1.36 | 1.34 | 1.44 |
Quick Ratio | 0.21 | 0.66 | 0.62 | 0.82 | 0.99 | 0.93 |
Current Ratio | 1.12 | 1.09 | 1.46 | 1.27 | 1.42 | 1.44 |
Return on Equity (ROE) | 5.71% | 6.65% | 7.30% | 6.82% | 11.21% | 9.49% |
Return on Assets (ROA) | 5.31% | 4.65% | 4.28% | 4.01% | 5.25% | 4.56% |
Return on Invested Capital (ROIC) | 9.02% | 9.24% | 8.47% | 8.09% | 10.19% | 8.89% |
Return on Capital Employed (ROCE) | 11.00% | 9.80% | 8.60% | 7.90% | 10.10% | 8.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 4.11% | 7.76% | 4.75% | 4.80% | 7.43% | 5.60% |
FCF Yield | 10.33% | 8.93% | 6.28% | 7.68% | 7.99% | 8.13% |
Dividend Yield | 5.12% | 4.94% | 4.20% | 4.18% | 3.96% | 3.75% |
Payout Ratio | 133.01% | 61.08% | 84.60% | 82.48% | 49.79% | 64.41% |
Buyback Yield / Dilution | 2.18% | 2.43% | 0.02% | 0.04% | 0.08% | 0.18% |
Total Shareholder Return | 7.35% | 7.37% | 4.23% | 4.22% | 4.04% | 3.93% |